BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3718142)

  • 21. Eosinophilic leukemic transformation in polycythemia rubra vera (PRV).
    Chim CS; Ma SK
    Leuk Lymphoma; 2005 Mar; 46(3):447-50. PubMed ID: 15621837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinopathy secondary to anemia from myeloid metaplasia in polycythemia vera.
    Blood AM; Lowenthal EA; Nowakowski RW
    J Am Optom Assoc; 1997 Nov; 68(11):734-8. PubMed ID: 9409109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hydroxyurea-induced pneumonitis].
    Schwonzen M; Spangenberger H; Spengler M
    Med Klin (Munich); 2003 Jul; 98(7):394-7. PubMed ID: 12937905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycythemia vera in a patient with the human immunodeficiency virus: a case report.
    Sassaki MG; Souza CA; Siciliano RF; Leite AG; Padilha SL
    Braz J Infect Dis; 2000 Aug; 4(4):204-7. PubMed ID: 11184768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea for Treatment of Nephrotic Syndrome Associated With Polycythemia Vera.
    Hundemer GL; Rosales IA; Chen YB; Colvin RB; Tolkoff-Rubin NE
    Am J Kidney Dis; 2016 Sep; 68(3):465-8. PubMed ID: 27133437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term management of polycythemia vera with hydroxyurea: a progress report.
    Kaplan ME; Mack K; Goldberg JD; Donovan PB; Berk PD; Wasserman LR
    Semin Hematol; 1986 Jul; 23(3):167-71. PubMed ID: 3749925
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of dilated cardiomyopathy caused by myocardial microinfarcts in the course of polycythemia vera].
    Konopka A; Stepińska J; Banaszewski M; Szajewski T
    Pol Merkur Lekarski; 1998 Jan; 4(19):26-8. PubMed ID: 9583943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycythemia vera terminating in myeloblastic transformation and myelofibrosis with tumor formation.
    Yonemitsu H; Okuda K; Niwa Y; Kondo Y
    Nihon Ketsueki Gakkai Zasshi; 1983 Jul; 46(4):822-6. PubMed ID: 6579811
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydroxyurea and lower leg ulcers.
    Nguyen TV; Margolis DJ
    Cutis; 1993 Oct; 52(4):217-9. PubMed ID: 8261806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous sarcoidosis and polycythemia vera.
    Pascual JC; Belinchón I; Albares P; Vergara G; Betlloch I; Bañuls J
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):700-1. PubMed ID: 15482300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-polycythemia myeloid metaplasia: experience with a large cohort of patients.
    Randi ML; Barbone E; Fabris F; Varotto L; Macri C; Girolami A
    J Med; 1994; 25(6):363-9. PubMed ID: 7769374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T; Kutluay L; Ozyilkan O
    Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
    Ellis AK; Lee DH
    Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
    [No Abstract]   [Full Text] [Related]  

  • 35. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
    Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera.
    Davidovitz Y; Lev D; Ballin A; Tsudik A; Meytes D
    Cancer Genet Cytogenet; 1998 Mar; 101(2):156-8. PubMed ID: 9494620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
    Litam PP; Landaw SA; Zamkoff KW
    Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycythemia vera in a 12-year-old girl: a case report.
    Turker M; Ozer EA; Oniz H; Atabay B; Yaprak I
    Pediatr Hematol Oncol; 2002 Jun; 19(4):263-6. PubMed ID: 12051593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels.
    Bush RK; Geller M; Busse WW; Flaherty DK; Dickie HA
    Arch Intern Med; 1978 Aug; 138(8):1244-6. PubMed ID: 677979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.